Article info
PDFEditorial
Gut microbiota-derived metabolites in atrial fibrillation: risk markers or modifiable risk factors?
- Correspondence to Dr Dominik Linz, Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin, Maastricht UMC+, Maastricht, 6229 HX, The Netherlands; Dominik.Linz{at}gmx.de
Citation
Gut microbiota-derived metabolites in atrial fibrillation: risk markers or modifiable risk factors?
Publication history
- First published January 2, 2023.
Online issue publication
February 14, 2023
Article Versions
- Previous version (2 January 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.